Europlasma Valuation
| ALEUP Stock | EUR 0.03 0.0008 2.35% |
Europlasma seems to be fairly valued based on Macroaxis valuation methodology. Our model computes the value of Europlasma SA from reviewing the firm fundamentals such as Profit Margin of (0.27) %, current valuation of 6.76 M, and Shares Outstanding of 5.59 M as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Europlasma's price fluctuation is out of control at this time. Calculation of the real value of Europlasma SA is based on 3 months time horizon. Increasing Europlasma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Europlasma's intrinsic value may or may not be the same as its current market price of 0.03, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0333 | Real 0.032 | Hype 0.03 | Naive 0.0253 |
The intrinsic value of Europlasma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Europlasma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Europlasma SA helps investors to forecast how Europlasma stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Europlasma more accurately as focusing exclusively on Europlasma's fundamentals will not take into account other important factors: Europlasma Total Value Analysis
Europlasma SA is presently projected to have takeover price of 6.76 M with market capitalization of 9.33 M, debt of 2.92 M, and cash on hands of 3.92 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Europlasma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.76 M | 9.33 M | 2.92 M | 3.92 M |
Europlasma Investor Information
The company has price-to-book (P/B) ratio of 0.26. Some equities with similar Price to Book (P/B) outperform the market in the long run. Europlasma SA recorded a loss per share of 4054.91. The entity had not issued any dividends in recent years. The firm had 5000:1 split on the 25th of May 2024. Based on the key measurements obtained from Europlasma's financial statements, Europlasma SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Europlasma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Europlasma has an asset utilization ratio of 24.24 percent. This connotes that the Company is making €0.24 for each dollar of assets. An increasing asset utilization means that Europlasma SA is more efficient with each dollar of assets it utilizes for everyday operations.Europlasma Profitability Analysis
The company reported the revenue of 9.8 M. Net Loss for the year was (12.67 M) with profit before overhead, payroll, taxes, and interest of 5.65 M.About Europlasma Valuation
The stock valuation mechanism determines Europlasma's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Europlasma SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Europlasma. We calculate exposure to Europlasma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Europlasma's related companies.Europlasma S.A., together with its subsidiaries, engages in plasma solutions, renewable energies, and asbestos waste treatment activities in France. Europlasma S.A. was founded in 1992 and is based in Pessac, France. EUROPLASMA operates under Waste Management classification in France and is traded on Paris Stock Exchange. It employs 116 people.
8 Steps to conduct Europlasma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Europlasma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Europlasma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Europlasma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Europlasma's revenue streams: Identify Europlasma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Europlasma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Europlasma's growth potential: Evaluate Europlasma's management, business model, and growth potential.
- Determine Europlasma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Europlasma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Europlasma Stock Analysis
When running Europlasma's price analysis, check to measure Europlasma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Europlasma is operating at the current time. Most of Europlasma's value examination focuses on studying past and present price action to predict the probability of Europlasma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Europlasma's price. Additionally, you may evaluate how the addition of Europlasma to your portfolios can decrease your overall portfolio volatility.